The clinical diagnosis of isolated cases of YF or identification of vaccine-associated 9 adverse events (YFVAE) is particularly difficult because the symptoms are quite similar 10 to those of many other diseases (20). Laboratory confirmation is therefore essential and 11 relies on the detection of YF-specific IgM or a fourfold or greater rise in serum IgG levels 12 The average viral load detected in positive samples was 8.8+E02 genome 48 equivalents (GE)/ml, ranging between 30 and 70 GE/ml (n=4 samples) to 10 4 GE/ml 49 (n=1 sample), without any significant difference regarding the day of sample collection. 50
It has been reported that a low transient viremia is detectable on YF-17D vaccinees 4 51 to 6 days after vaccination and do not exceed 2.3 log 10 PFU/ml or 2.23 log 10 copies/ml 52 (12, 16, 19) . However, higher levels have been reported in wild type infections (2, 14) 53 and severe YFVAE (4, 7, 13). The results presented are in agreement with these 54 observations and deserve being thoroughly studied. A large scale study to determine the 55 features of YFV-17D shedding in urine, and the correlation with viremia levels is 56 ongoing. It would be highly desirable to explore the presence of YFV genome in wild-57 type cases, as we would then be able to anticipate that YF genome could be present in 58 the urine of the patients during the course of the disease, providing a feature that could 59 be extremely useful for diagnosis and identification of clinical cases. 
